Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2026 Earnings Call Transcript May 6, 2026
Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, expectations were $-0.01.
Operator: Hello, and welcome to Vir Biotechnology, Inc. First Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded. After the speakers’ presentation, there will be a question and answer session. I will now turn the call over to Kiki Patel, Head...
